Author

Kaustav A. Gopinathan

Harvard UniversityORCID 0000-0002-4082-1052Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1

Frequent Co-Authors

Aditya BardiaiD· 2 shared Akansha Deshpande· 2 shared Avanish MishraiD· 2 shared Daniel A. HaberiD· 2 shared David Tsai TingiD· 2 shared Jon F.iD· 2 shared Linda T. NiemaniD· 2 shared Mehmet ToneriD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aditya BardiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJun 17, 2026

✦ In-depth digest

Dynamic Monitoring of Antibody Drug Conjugates Targeting TROP2 or HER2 in Breast Cancer using Circulating Tumor Cells

Avanish Mishra, Rachel O. Abelman, Quinn E. Cunneely…·Shyamala Maheswaran

In metastatic breast cancer on TROP2- or HER2-targeting antibody-drug conjugates, early CTC disappearance or steep decline tracked response, while CTC epitope levels neither predicted benefit nor vanished at resistance.

9 citationstop 1%

humanimaging

𝕏 PostBluesky

BioengineeringNature CommunicationsPeer-reviewedJan 2, 2025

Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product

Avanish Mishra, Shih‐Bo Huang, Taronish D. Dubash…·Mehmet Toner

This study uses high-throughput microfluidic technology to enrich CTCs from large blood volumes, enabling detailed molecular and morphological analysis of tumor cells in metastatic cancer patients.

62 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky